NCT03963401 A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT03962465 Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03961997 Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants Status COMPLETED Phase PHASE1
NCT03954158 Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03950232 An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03943615 Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Status NO_LONGER_AVAILABLE Phase N/A
NCT03938792 Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B Status COMPLETED Phase PHASE3
NCT03937258 A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants Status COMPLETED Phase PHASE1
NCT03936270 Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer Status COMPLETED Phase PHASE2
NCT03934086 An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine Status NO_LONGER_AVAILABLE Phase N/A
NCT03929510 Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600. Status COMPLETED Phase PHASE1
NCT03923426 Real-World Observational Study Of Zavicefta to Characterize Use Patterns Status COMPLETED Phase N/A
NCT03916458 REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Status COMPLETED Phase N/A
NCT03916406 THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS Status COMPLETED Phase PHASE1